Skip to content
2000
Volume 21, Issue 13
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Cancer is an uncontrolled malignant tumor growth taking place in any tissue of the body and attains complex diversity which makes it difficult for oncologists to choose therapeutics. The changes leading to formation of cancerous cells occur due to a series of molecular events. Now scientists are trying to understand the various molecular processes that are involved in the growth of cancers. This article presents a brief account of epigenetics with reference to DNA methylation and histone modification as an important contributor to the formation of cancer cells. Drug targeting the epigenetic regulators has been considered for various types of cancer. The enzymes in DNA methylation and histone modification, FDA approved clinical drugs along with the challenges associated with the development of anti-cancer target based therapeutics are summarized.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/1871520620999201117111139
2021-09-01
2025-06-30
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/1871520620999201117111139
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test